REQUEST A DEMO
Total
USD $0.00
Search more companies

Ips Curativ Clinica de Heridas Hiperbarica S.A.S. (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Ips Curativ Clinica de Heridas Hiperbarica S.A.S. Profile Updated: July 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Ips Curativ Clinica de Heridas Hiperbarica S.A.S. is a company in Colombia, with a head office in Medellin. It operates in the Ambulatory Health Care Services sector. The company was established on January 22, 2018. 12 (2024) employees currently work for Ips Curativ Clinica de Heridas Hiperbarica S.A.S.. The company’s latest financial report indicates a net sales revenue increase of 220.85% in 2023. There was a total growth of 275.55% in Ips Curativ Clinica de Heridas Hiperbarica S.A.S.’s total assets over the same period. The net profit margin of Ips Curativ Clinica de Heridas Hiperbarica S.A.S. increased by 30.14% in 2023.

Headquarters
Calle 49 B 76 A 74
Medellin; Antioquia;

Contact Details: Purchase the Ips Curativ Clinica de Heridas Hiperbarica S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Ips Curativ Clinica de Heridas Hiperbarica S.A.S. report to view the information.
Outstanding Shares:
Purchase the Ips Curativ Clinica de Heridas Hiperbarica S.A.S. report to view the information.
Incorporation Date:
January 22, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Ips Curativ Clinica de Heridas Hiperbarica S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
220.85%
Total operating revenue
220.85%
Operating profit (EBIT)
446.53%
EBITDA
426.86%
Net Profit (Loss) for the Period
3022.48%
Total assets
275.55%
Total equity
341.39%
Operating Profit Margin (ROS)
15.15%
Net Profit Margin
30.14%
Return on Equity (ROE)
66.41%
Quick Ratio
1.4%
Cash Ratio
0.18%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?